Hypophysitis is mainly associated with anti-CTLA4 mAbs (3.9–8.1%), whereas thyroid dysfunction is predominantly associated with anti-PD-1/PD-L1 mAbs (6.4–9.8%) [37,39]. Here, PDCD1 is linked to hypophysitis.